Form 4: UnitedHealth Group Director Receives Dividend Equivalents on Deferred Stock Units
Insider Transaction Report
UnitedHealth Group Director John H. Noseworthy acquired 42 shares of common stock as dividend equivalents on vested deferred stock units, increasing his total beneficial ownership to 6,105 shares.
Summary
- John H. Noseworthy, a Director of UnitedHealth Group Inc. (UNH), acquired 42 shares of common stock.
- The transaction occurred on June 24, 2025.
- These shares represent dividend equivalents paid on vested deferred stock units.
- The dividend equivalents were immediately vested and are subject to the same terms as the underlying deferred stock units.
- Following this transaction, Mr. Noseworthy beneficially owns a total of 6,105 shares of UnitedHealth Group common stock.
- The acquisition price for these shares was $0, which is typical for dividend equivalent payments.
Sentiment
Score: 5
Explanation: The document reports a routine insider transaction (dividend equivalents) which is neutral in sentiment, reflecting standard compensation practices rather than new positive or negative developments.
Positives
- Director's beneficial ownership of UnitedHealth Group common stock increased by 42 shares, aligning his interests further with shareholders.
- The acquisition of shares through dividend equivalents is a standard, non-cash compensation mechanism for vested deferred stock units, indicating routine corporate compensation practices.
Future Outlook
NA
Industry Context
This Form 4 filing details a routine insider transaction related to director compensation and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders: The transaction represents a minor increase in a director's equity ownership, which can be seen as a positive for alignment of interests, though the impact is minimal given the small number of shares relative to the company's total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 06/24/2025 | Date of earliest transaction, representing the acquisition of 42 shares of common stock. |
| 06/26/2025 | Date the SEC Form 4 was filed. |
Keywords
UnitedHealth Group, UNH, Form 4, insider transaction, director, stock ownership, dividend equivalents, deferred stock units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.